Production (Stage)
Turnstone Biologics Corp.
TSBX
$0.3329
-$0.0065-1.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.85% | 21.75% | 1.66% | 0.91% | -28,966.18% |
| Total Depreciation and Amortization | -40.86% | -48.86% | -29.86% | -31.78% | -28.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 820.14% | 363.16% | -76.96% | -56.41% | -78.07% |
| Change in Net Operating Assets | 28.57% | -2,134.60% | 62.85% | -11.15% | 107.12% |
| Cash from Operations | 59.39% | -6.27% | 6.44% | -8.40% | -1.69% |
| Capital Expenditure | -- | -- | 100.39% | 4.55% | 83.64% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 100.00% | -60.32% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 481.03% | 157.75% | 529.42% | -17.46% |
| Cash from Investing | -99.91% | 500.92% | 157.38% | 536.67% | -14.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 1,366.67% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -78.07% | 65.80% | -- |
| Cash from Financing | -- | 100.00% | -99.92% | 81.95% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.37% | 122.85% | -60.96% | 124.77% | -126.60% |